{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:08:15Z","timestamp":1793916495007,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03934-y","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T09:26:17Z","timestamp":1736241977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Real-world effectiveness of hemodialysis modalities: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n Alejos","family":"Ferreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Carioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Arkossy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len A.","family":"Usvyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Stuard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin W.","family":"Maddux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"issue":"10225","key":"3934_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"2","key":"3934_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, Nee R. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98\u2013107.","journal-title":"Am J Nephrol"},{"key":"3934_CR3","unstructured":"United States Renal Data System. 2023 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2023. https:\/\/usrds-adr.niddk.nih.gov\/2023. Accessed 21 Feb 2024."},{"issue":"1","key":"3934_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41100-023-00497-w","volume":"9","author":"T Fiseha","year":"2023","unstructured":"Fiseha T, Osborne NJ. Burden of end-stage renal disease of undetermined etiology in Africa. Ren Replace Ther. 2023;9(1):44.","journal-title":"Ren Replace Ther"},{"issue":"1","key":"3934_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/j.ajkd.2018.12.033","volume":"74","author":"V Briggs","year":"2019","unstructured":"Briggs V, Davies S, Wilkie M. International variations in peritoneal dialysis utilization and implications for practice. Am J Kidney Dis. 2019;74(1):101\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3934_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","volume":"16","author":"J Himmelfarb","year":"2020","unstructured":"Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16(10):573\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 4","key":"3934_CR7","doi-asserted-by":"publisher","first-page":"i45","DOI":"10.1093\/ckj\/sfab198","volume":"14","author":"B Canaud","year":"2021","unstructured":"Canaud B, Stuard S, Laukhuf F, Yan G, Canabal MIG, Lim PS, Kraus MA. Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine. Clin Kidney J. 2021;14(Suppl 4):i45\u201358.","journal-title":"Clin Kidney J"},{"issue":"2","key":"3934_CR8","doi-asserted-by":"publisher","first-page":"e033228","DOI":"10.1136\/bmjopen-2019-033228","volume":"10","author":"PJ Blankestijn","year":"2020","unstructured":"Blankestijn PJ, Fischer KI, Barth C, Cromm K, Canaud B, Davenport A, Grobbee DE, Hegbrant J, Roes KC, Rose M, Strippoli GF, Vernooij RW, Woodward M, de Wit GA, Bots ML. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol. BMJ Open. 2020;10(2):e033228.","journal-title":"BMJ Open"},{"issue":"S2","key":"3934_CR9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1111\/hdi.12702","volume":"22","author":"S Haroon","year":"2018","unstructured":"Haroon S, Davenport A. Choosing a dialyzer: what clinicians need to know. Hemodial Int. 2018;22(S2):S65\u201374.","journal-title":"Hemodial Int"},{"issue":"5","key":"3934_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/sdi.13085","volume":"35","author":"LH Ficociello","year":"2022","unstructured":"Ficociello LH, Busink E, Sawin DA, Winter A. Global real-world data on hemodiafiltration: an opportunity to complement clinical trial evidence. Semin Dial. 2022;35(5):440\u20135.","journal-title":"Semin Dial"},{"issue":"8","key":"3934_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1525-1594.2007.00436.x","volume":"31","author":"K Lee","year":"2007","unstructured":"Lee K, Jeong JH, Mun CH, Lee SR, Yoo KJ, Park YW, Won YS, Min BG. Convection-enhanced high-flux hemodialysis. Artif Organs. 2007;31(8):653\u20138.","journal-title":"Artif Organs"},{"issue":"3","key":"3934_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1046\/j.1523-1755.1998.00049.x","volume":"54","author":"C Ronco","year":"1998","unstructured":"Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G. Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int. 1998;54(3):979\u201385.","journal-title":"Kidney Int"},{"issue":"2","key":"3934_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000476053","volume":"44","author":"C Donadio","year":"2017","unstructured":"Donadio C, Kanaki A, Sami N, Tognotti D. High-flux dialysis: clinical, biochemical, and proteomic comparison with low-flux dialysis and on-line hemodiafiltration. Blood Purif. 2017;44(2):129\u201339.","journal-title":"Blood Purif"},{"issue":"3","key":"3934_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ndt\/gfz005","volume":"35","author":"B Canaud","year":"2020","unstructured":"Canaud B, K\u00f6hler K, Sichart JM, M\u00f6ller S. Global prevalent use, trends and practices in haemodiafiltration. Nephrol Dial Transpl. 2020;35(3):398\u2013407.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"3934_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/toxins15090531","volume":"15","author":"C Pedreros-Rosales","year":"2023","unstructured":"Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P. Unveiling the clinical benefits of high-volume hemodiafiltration: optimizing the removal of medium-weight uremic toxins and beyond. Toxins (Basel). 2023;15(9):531.","journal-title":"Toxins (Basel)"},{"issue":"6","key":"3934_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfv349","volume":"31","author":"SAE Peters","year":"2016","unstructured":"Peters SAE, Bots ML, Canaud B, Davenport A, Grooteman MP, Kircelli F, Locatelli F, Maduell F, Morena M, Nub\u00e9 MJ, Ok E, Torres F, Woodward M, Blankestijn P, HDF Pooling Project Investigators. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transpl. 2016;31(6):978\u201384.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"3934_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1681\/ASN.2012080875","volume":"24","author":"F Maduell","year":"2013","unstructured":"Maduell F, Moreso F, Pons M, Ramos R, Mora-Maci\u00e0 J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A, ESHOL Study Group. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487\u201397.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3934_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/ki.2015.264","volume":"89","author":"A Davenport","year":"2016","unstructured":"Davenport A, Peters SAE, Bots ML, et al. HDF Pooling Project investigators. Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size. Kidney Int. 2016;89(1):193\u20139. https:\/\/doi.org\/10.1038\/ki.2015.264","journal-title":"Kidney Int"},{"issue":"3","key":"3934_CR19","first-page":"548","volume":"32","author":"MJ Nub\u00e9","year":"2017","unstructured":"Nub\u00e9 MJ, Peters SAE, Blankestijn PJ, Canaud B, Davenport A, Grooteman MPC, Asci G, Locatelli F, Maduell F, Morena M, Ok E, Torres F, Bots ML. HDF Pooling Project investigators. Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis. Nephrol Dial Transpl. 2017;32(3):548\u201355.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"3934_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1681\/ASN.2011121140","volume":"23","author":"MPC Grooteman","year":"2012","unstructured":"Grooteman MPC, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, L\u00e9vesque R, Nub\u00e9 MJ, ter Wee PM, Blankestijn PJ. CONTRAST investigators. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23(6):1087\u201396.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3934_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ndt\/gfs407","volume":"28","author":"E Ok","year":"2013","unstructured":"Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, Hur E, Demirci MS, Demirci C, Duman S, Basci A, Adam SM, Isik IO, Zengin M, Suleymanlar G, Yilmaz ME, Ozkahya M. Turkish online Haemodiafiltration Study. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF study. Nephrol Dial Transpl. 2013;28(1):192\u2013202.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"3934_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2215\/CJN.07140713","volume":"9","author":"IM Mostovaya","year":"2014","unstructured":"Mostovaya IM, Bots ML, van den Dorpel MA, Grooteman MP, Kamp O, Levesque R, Ter Wee PM, Nub\u00e9 MJ, Blankestijn PJ. A randomized trial of hemodiafiltration and change in cardiovascular parameters. Clin J Am Soc Nephrol. 2014;9(3):520\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3934_CR23","doi-asserted-by":"crossref","unstructured":"Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2015(5):CD006258.","DOI":"10.1002\/14651858.CD006258.pub2"},{"issue":"8","key":"3934_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMoa2304820","volume":"389","author":"PJ Blankestijn","year":"2023","unstructured":"Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, Barth C, Covic A, Cromm K, Cucui A, Davenport A, Rose M, T\u00f6r\u00f6k M, Woodward M, Bots ML, CONVINCE Scientific Committee Investigators. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med. 2023;389(8):700\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"3934_CR25","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/ndt\/gfad136","volume":"38","author":"R Shroff","year":"2023","unstructured":"Shroff R, Basile C, van der Sande F, Mitra S, EuDial Working Group of the European Renal Association. Haemodiafiltration for all: are we CONVINCEd? Nephrol Dial Transpl. 2023;38(12):2663\u20135.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"3934_CR26","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/ndt\/gfac019","volume":"37","author":"RWM Vernooij","year":"2022","unstructured":"Vernooij RWM, Bots ML, Strippoli GFM, Canaud B, Cromm K, Woodward M, Blankestijn PJ. CONVINCE Scientific Committee. CONVINCE in the context of existing evidence on haemodiafiltration. Nephrol Dial Transpl. 2022;37(6):1006\u201313.","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"3934_CR27","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1093\/ckj\/sfad258","volume":"16","author":"KJ Mayne","year":"2023","unstructured":"Mayne KJ, Ronco C. Will another trial CONVINCE nephrologists to adopt high-dose haemodiafiltration over conventional haemodialysis? Clin Kidney J. 2023;16(12):2393\u20135.","journal-title":"Clin Kidney J"},{"issue":"1","key":"3934_CR28","doi-asserted-by":"publisher","first-page":"sfad247","DOI":"10.1093\/ckj\/sfad247","volume":"17","author":"P Meena","year":"2023","unstructured":"Meena P, Locatelli F. Unmasking the CONVINCE trial: is hemodiafiltration ready to steal the spotlight in real-world practice? Clin Kidney J. 2023;17(1):sfad247.","journal-title":"Clin Kidney J"},{"issue":"Suppl 4","key":"3934_CR29","first-page":"S94","volume":"14","author":"D Marcelli","year":"2001","unstructured":"Marcelli D, Kirchgessner J, Amato C, Steil H, Mitteregger A, Moscard\u00f2 V, Carioni C, Orlandini G, Gatti E. EuCliD (European Clinical Database): a database comparing different realities. J Nephrol. 2001;14(Suppl 4):S94\u2013100.","journal-title":"J Nephrol"},{"issue":"1","key":"3934_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-0038-1633841","volume":"43","author":"H Steil","year":"2004","unstructured":"Steil H, Amato C, Carioni C, Kirchgessner J, Marcelli D, Mitteregger A, Moscardo V, Orlandini G, Gatti E. EuCliD\u00ae \u2013 a medical registry. Methods Inf Med. 2004;43(1):83\u20138.","journal-title":"Methods Inf Med"},{"issue":"6","key":"3934_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1053\/j.ajkd.2012.12.017","volume":"61","author":"E Hur","year":"2013","unstructured":"Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013;61(6):957\u201365.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3934_CR32","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/cvr\/cvac195","volume":"119","author":"EYF Wan","year":"2023","unstructured":"Wan EYF, Mathur S, Zhang R, Yan VKC, Lai FTT, Chui CSL, Li X, Wong CKH, Chan EWY, Yiu KH, Wong ICK. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank. Cardiovasc Res. 2023;119(8):1718\u201327.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"3934_CR33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/ckj\/sfw140","volume":"10","author":"CLM de Roij","year":"2017","unstructured":"de Roij CLM, Chapdelaine I, Nub\u00e9 MJ, Blankestijn PJ, Bots ML, Konings CJAM, Kremer Hovinga TK, Molenaar FM, van der Weerd NC, Grooteman MPC. Achieving high convection volumes in postdilution online hemodiafiltration: a prospective multicenter study. Clin Kidney J. 2017;10(6):804\u201312.","journal-title":"Clin Kidney J"},{"issue":"6","key":"3934_CR34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11255-013-0526-8","volume":"46","author":"G Imamovi\u0107","year":"2014","unstructured":"Imamovi\u0107 G, Hrva\u010devi\u0107 R, Kapun S, Marcelli D, Bayh I, Grassmann A, Scatizzi L, Maslovari\u0107 J, Canaud B. Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis. Int Urol Nephrol. 2014;46(6):1191\u2013200.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"3934_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000371446","volume":"129","author":"B Canaud","year":"2015","unstructured":"Canaud B, Bayh I, Marcelli D, Ponce P, Merello JI, Gurevich K, Ladanyi E, Ok E, Imamovic G, Grassmann A, Scatizzi L, Gatti E. Improved survival of incident patients with high-volume haemodiafiltration: a propensity-matched cohort study with inverse probability of censoring weighting. Nephron. 2015;129(3):179\u201388.","journal-title":"Nephron"},{"key":"3934_CR36","unstructured":"ERA Registry. ERA Registry annual report 2021. ERA Registry, Department of Medical Informatics. 2023. https:\/\/www.era-online.org\/wp-content\/uploads\/2023\/12\/ERA-Registry-Annual-Report-2021_231206.pdf. Accessed 21 Feb 2024."},{"issue":"4","key":"3934_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.kint.2020.05.039","volume":"98","author":"R Boenink","year":"2020","unstructured":"Boenink R, Stel VS, Waldum-Grevbo BE, Collart F, Kerschbaum J, Heaf JG, de Meester J, Finne P, Garc\u00eda-Marcos SA, Evans M, Amb\u00fchl PM, Arici M, Ayav C, Steenkamp R, Cases A, Traynor JP, Palsson R, Zoccali C, Massy ZA, Jager KJ, Kramer A. Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy. Kidney Int. 2020;98(4):999\u20131008.","journal-title":"Kidney Int"},{"issue":"5","key":"3934_CR38","first-page":"473","volume":"102","author":"JE Burmeister","year":"2014","unstructured":"Burmeister JE, Mosmann CB, Costa VB, Saraiva RT, Grandi RR, Bastos JP, Gon\u00e7alves LF, Rosito GA. Prevalence of cardiovascular risk factors in hemodialysis patients \u2013 the CORDIAL study. Arq Bras Cardiol. 2014;102(5):473\u201380.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"3934_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/nep.14033","volume":"27","author":"AA Bonenkamp","year":"2022","unstructured":"Bonenkamp AA, Vonk S, Abrahams AC, Vermeeren YM, van Eck A, Hoekstra T, van Ittersum FJ, van Jaarsveld BC, DOMESTICO Study Group. Comorbidity is not associated with dialysis modality choice in patients with end-stage kidney disease. Nephrol (Carlton). 2022;27(6):510\u20138.","journal-title":"Nephrol (Carlton)"},{"key":"3934_CR40","doi-asserted-by":"crossref","unstructured":"Vernooij RWM, Hockham C, Strippoli G, Green S, Hegbrant J, Davenport A, Barth C, Canaud B, Woodward M, Blankestijn PJ, Bots ML, CONVINCE Scientific Committee. Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials. Lancet. 2024;404(10464):1742-9.","DOI":"10.1016\/S0140-6736(24)01859-2"},{"issue":"1","key":"3934_CR41","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13063-022-06357-y","volume":"23","author":"FJ Caskey","year":"2022","unstructured":"Caskey FJ, Procter S, MacNeill SJ, Wade J, Taylor J, Rooshenas L, Liu Y, Annaw A, Alloway K, Davenport A, Power A, Farrington K, Mitra S, Wheeler DC, Law K, Lewis-White H, Ben-Shlomo Y, Hollingworth W, Donovan J, Lane JA. The high-volume haemodiafiltration vs high-flux Haemodialysis Registry Trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes. Trials. 2022;23(1):532.","journal-title":"Trials"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T22:03:18Z","timestamp":1736287398000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3934"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03934-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethics Committee of the Landes\u00e4rztekammer Hessen (Medical Association of Hesse) in Frankfurt, Germany. All patients provided written informed consent for the secondary use of their data for scientific research purposes. In addition, pseudonymized data was extracted from the European Clinical Database (EuCliD<sup>\u00ae<\/sup>) database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}